Covered recipient · General Payments record
ARASH BAHRAMI
Allopathic & Osteopathic Physicians Otolaryngology
General Payments · PY2019–2024
$2,969.28
- Reported across 79 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $325.27 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| OptiNose US, Inc. | $167.94 | 8 |
| GENZYME CORPORATION | $70.92 | 3 |
| GlaxoSmithKline, LLC. | $40.66 | 2 |
| Integra LifeSciences Corporation | $27.08 | 1 |
| Hikma Pharmaceuticals USA | $18.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| GENZYME CORPORATION | $23.49 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139588889 | CMS |
| GENZYME CORPORATION | $19.82 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139588931 | CMS |
| GENZYME CORPORATION | $27.61 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139588955 | CMS |
| GlaxoSmithKline, LLC. | $20.82 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116691617 | CMS |
| GlaxoSmithKline, LLC. | $19.84 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116609548 | CMS |
| Hikma Pharmaceuticals USA | $18.67 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127506440 | CMS |
| Integra LifeSciences Corporation | $27.08 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140076338 | CMS |
| Optinose US, Inc. | $24.88 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142170328 | CMS |
| Optinose US, Inc. | $11.26 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142170342 | CMS |
| Optinose US, Inc. | $18.74 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142170344 | CMS |
| Optinose US, Inc. | $24.55 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142170402 | CMS |
| Optinose US, Inc. | $20.73 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142170360 | CMS |
| Optinose US, Inc. | $24.03 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142170412 | CMS |
| Optinose US, Inc. | $15.84 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142170410 | CMS |
| Optinose US, Inc. | $27.91 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142170446 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.